References
1. Huby, T., & Gautier, E. L. (2021). Immune cell-mediated features of non-alcoholic steatohepatitis. Nature Reviews. Immunology, 1-15. Advance online publication.
2. Abdelmalek, M. F. (2021). Non-alcoholic fatty liver disease: another leap forward. Nature reviews. Gastroenterology & hepatology, 18 (2),85-86.
3. Raza, S., Rajak, S., Upadhyay, A., Tewari, A., & Anthony Sinha, R. (2021). Current treatment paradigms and emerging therapies for NAFLD/NASH. Frontiers in bioscience (Landmark edition), 26 (2), 206-237.
4. Yoo, J. J., Kim, W., Kim, M. Y., Jun, D. W., Kim, S. G., Yeon, J. E., Lee, J. W., Cho, Y. K., Park, S., Sohn, J. H., & the Korean Association for the Study of the Liver (KASL)-Korea Non-alcoholic fatty liver Study Group (KNSG) (2019). Recent research trends and updates on non-alcoholic fatty liver disease. Clinical and molecular hepatology, 25 (1), 1-11.
5. Kang, S. H., Lee, H. W., Yoo, J. J., Cho, Y., Kim, S. U., Lee, T. H., Jang, B. K., Kim, S. G., Ahn, S. B., Kim, H., Jun, D. W., Choi, J. I., Song, D. S., Kim, W., Jeong, S. W., Kim, M. Y., Koh, H., Jeong, S., Lee, J. W., Cho, Y. K.,… Korean Association for the Study of the Liver (KASL) (2021). KASL clinical practice guidelines: Management of non-alcoholic fatty liver disease. Clinical and molecular hepatology, 27 (3), 363-401.
6. Lee, H. L., Lee, J., Cha, J. H., Cho, S., Sung, P. S., Hur, W., Yoon, S. K., & Bae, S. H. (2022). Anti-fibrotic effects of branched-chain amino acids on hepatic stellate cells. The Korean journal of internal medicine, 37 (1), 53-62.
7. Xiong, X., Kuang, H., Ansari, S., Liu, T., Gong, J., Wang, S., Zhao, X. Y., Ji, Y., Li, C., Guo, L., Zhou, L., Chen, Z., Leon-Mimila, P., Chung, M. T., Kurabayashi, K., Opp, J., Campos-Perez, F., Villamil-Ramirez, H., Canizales-Quinteros, S., Lyons, R.,…Lin, J. D. (2019). Landscape of Intercellular Crosstalk in Healthy and NASH Liver Revealed by Single-Cell Secretome Gene Analysis. Molecular cell, 75 (3), 644-660.e5.
8. Seidman, J. S., Troutman, T. D., Sakai, M., Gola, A., Spann, N. J., Bennett, H., Bruni, C. M., Ouyang, Z., Li, R. Z., Sun, X., Vu, B. T., Pasillas, M. P., Ego, K. M., Gosselin, D., Link, V. M., Chong, L. W., Evans, R. M., Thompson, B. M., McDonald, J. G., Hosseini, M.,…Glass, C. K. (2020). Niche-Specific Reprogramming of Epigenetic Landscapes Drives Myeloid Cell Diversity in Nonalcoholic Steatohepatitis. Immunity, 52 (6), 1057-1074.e7.
9. Remmerie, A., Martens, L., Thone, T., Castoldi, A., Seurinck, R., Pavie, B., Roels, J., Vanneste, B., De Prijck, S., Vanhockerhout, M., Binte Abdul Latib, M., Devisscher, L., Hoorens, A., Bonnardel, J., Vandemme, N., Kremer, A., Borghgraef, P., Van Vlierberghe, H., Lippens, S., Pearce, E.,…Scott, C. L. (2020). Osteopontin Expression Identifies a Subset of Recruited Macrophages Distinct from Kupffer Cells in the Fatty Liver. Immunity, 53 (3), 641-657e14.
10. Tran, S., Baba, I., Poupel, L., Dussaud, S., Moreau, M., Gelineau, A., Marcelin, G., Magreau-Davy, E., Ouhachi, M., Lesnik, P., Boissonnas, A., Le Goff, W., Clausen, B. E., Yvan-Charvet, L., Sennlaub, F., Huby, T., & Gautier, E. L. (2020). Impaired Kupffer Cell Self-Renewal Alters the Liver Response to Lipid Overload during Non-alcoholic Steatohepatitis. Immunity, 53 (3), 627-640.e5.
11. Krenkel, O., Puengel, T., Govaere, O., Abdallah, A. T., Mossanen, J. C., Kohlhepp, M., Liepelt, A., Lefebvre, E., Luedde, T., Hellerbrand, C., Weiskirchen, R., Longerich, T., Costa, I. G., Anstee, Q. M., Trautwein, C., & Tacke, F. (2018). Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis. Hepatology (Baltimore, Md.), 67 (2), 1270-1283.
12. Sung, P. S. Crosstalk between tumour-associated macrophages and neighboring cells in hepatocellular carcinoma. Clinical and molecular hepatology. Advance online publication.
13. Sung, P. S., Kim, C. M., Cha, J. H., Park, J. Y., Yu, Y. S., Wang, H. J., Kim, J. K., & Bae, S. H. (2022). A Unique Immune-Related Gene Signature Represents Advanced Liver Fibrosis and Reveals Potential Therapeutic Targets. Biomedicines, 10 (1), 180.
14. Krenkel, O., Hundertmark, J., Abdallah, A. T., Kohlhepp, M., Puengel, T., Roth, T., Branco, D., Mossanen, J. C., Luedde, T., Trautwein, C., Costa, I. G., & Tacke, F. (2020). Myeloid cells in liver and bone marrow acquire a functionally distinct inflammatory phenotype during obesity-related steatohepatitis. Gut, 69 (3), 551-563.
15. Lee, S. W., Kim, S. M., Hur, W., Kang, B. Y., Lee, H. L., Nam, H., Yoo, S. H., Sung, P. S., Kwon, J. H., Jang, J. W., Kim, S. J., & Yoon, S. K. (2021). Tenofovir disoproxil fumarate directly ameliorates liver fibrosis by inducing hepatic stellate cell apoptosis via downregulation of PI3K/Akt/mTOR signalling pathway. PLoS One, 16 (12), e0261067.
16. Zhao, J., Han, M., Zhou, L., Liang, P., Wang, Y., Feng, S., Lu, H., Yuan, X., Han, K., Chen, X., Liu, S., & Cheng, J. (2020). TAF and TDF attenuate liver fibrosis through NS5ATP9, TGFbeta1/Smad3, and NF-kappaB/NLRP3 inflammasome signalling pathways. Hepatology international, 14 (1), 145-160.
17. Park, D. J., Sung, P. S., Kim, J. H., Lee, G. W., Jang, J. W., Jung, E. S., Bae, S. H., Choi, J. Y., & Yoon, S. K. (2020). EpCAM-high liver cancer stem cells resist natural killer cell-mediated cytotoxicity by upregulating CEACAM1. Journal for immunotherapy of cancer, 8 (1), e000301.
18. Sung, P. S., Park, D. J., Roh, P. R., Do Mun, K., Cho, S. W., Lee, G. W., Jung, E. S., Lee, S. H., Jang, J. W., Bae, S. H., Choi, J. Y., Choi, J., Ahn, J., & Yoon, S. K. (2022). Intrahepatic inflammatory IgA+ PD-L1-high monocytes in hepatocellular carcinoma development and immunotherapy. Journal for immunotherapy of cancer, 10 (5), e003618.
19. Ramachandran, P., Dobie, R., Wilson-Kanamori, J. R., Dora, E. F., Henderson, B. E. P., Luu, N. T. Portman, J. R., Matchett, K. P., Brice, M., Marwick, J. A., Taylor, R. S., Efremova, M., Vento-Tormo, R., Carragher, N. O., Kendall, T. J., Fallowfield, J. A., Harrison, E. M., Mole, D. J., Wigmore, S. J., Newsome, P. N., … Henderson, N. C. (2019). Resolving the fibrotic niche of human liver cirrhosis at single-cell level. Nature, 575 (7783), 512-518.
20. Saito, K., Uebanso, T., Maekawa, K., Ishikawa, M., Taguchi, R., Nammo, T., Nishimaki-Mogami, T., Udagawa, H., Fujii, M., Shibazaki, Y., Yoneyama, H., Yasuda, K., & Saito, Y. (2015). Characterization of hepatic lipid profiles in a mouse model with nonalcoholic steatohepatitis and subsequent fibrosis. Scientific reports, 5,12466.
21. Carpino, G., Del Ben, M., Pastori, D., Carnevale, R., Baratta, F., Overi, D., Francis, H., Cardinale, V., Onori, P., Safarikia, S., Cammisotto, V., Alvaro, D., Svegliati-Baroni, G., Angelico, F., Gaudio, E., & Violi, F. (2020). Increased Liver Localization of Lipopolysaccharides in Human and Experimental NAFLD. Hepatology (Baltimore, Md.), 72 (2), 470-485.
22. Sripongpun, P., Kim, W. R., Mannalithara, A., Kwong, A., Daugherty, T., Goel, A., & Kwo, P. Y. (2022). Tenofovir Alafenamide Attenuates Effects of Diabetes and Body Mass on Serum Alanine Aminotransferase Activities in Patients With Chronic Hepatitis B. Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association, 20 (1), 230-2.
23. Linton, M. F., Moslehi, J. J., & Babaev, V. R. (2019). Akt Signalling in Macrophage Polarization, Survival, and Atherosclerosis.International journal of molecular sciences, 20 (11), 2703.
24. Lopez-Pelaez, M., Soria-Castro, I., Bosca, L., Fernandez, M., & Alemany, S. (2011). Cot/tpl2 activity is required for TLR-induced activation of the Akt p70 S6k pathway in macrophages: Implications for NO synthase 2 expression. European journal of immunology, 41 (6), 1733-1741.
25. Lee, S. J., Seo, K. W., & Kim, C. D. (2015). LPS Increases 5-LO Expression on Monocytes via an Activation of Akt-Sp1/NF-kappaB Pathways.The Korean journal of physiology & pharmacology: official journal of the Korean Physiological Society and the Korean Society of Pharmacology, 19 (3), 263-268.